Yuflyma (adalimumab-aaty)
$3,533.18
This medicine requires a prescription. See “Prescription Guide”.
We can only help if the medicine is not available in your country. Learn more.
Yuflyma (adalimumab-aaty) is a prescription medicine for the treatment of multiple conditions, including plaque psoriasis, psoriatic and rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, enthesitis-related arthritis, axial spondyloarthritis, Crohn’s disease, ulcerative colitis, hidradenitis suppurativa, and non-infectious uveitis 1.
Yuflyma (adalimumab-aaty) is approved by the European Medicines Agency1.
Buy Yuflyma (adalimumab-aaty)
This medicine requires a prescription. See “Prescription Guide”.
We can only help if the medicine is not available in your country. Learn more.
Yuflyma (adalimumab-aaty) is a prescription medicine for the treatment of multiple conditions, including plaque psoriasis, psoriatic and rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, enthesitis-related arthritis, axial spondyloarthritis, Crohn’s disease, ulcerative colitis, hidradenitis suppurativa, and non-infectious uveitis 1.
| six single-dose pre-filled syringe x 40 mg/0.4 mL | 3,533.18 |
|---|
Be the first to review “Yuflyma (adalimumab-aaty)”
Related products
Psoriatic Arthritis
Psoriasis
Rheumatoid Arthritis
Psoriatic Arthritis
Psoriatic Arthritis
Psoriasis
Rheumatoid Arthritis
Reviews
There are no reviews yet.